Neuroscience

George E. Norcross III to Donate $100 Million to Cooper University Health Care/MD Anderson Cancer Center at Cooper in Honor of His Parents, George E. Norcross Jr. and Anne Carol Conner Norcross

Apollo Neuroscience Announces Publication of Landmark Clinical Study Demonstrating Apollo Wearable Use Yields an Average of 46 More Minutes of Sleep Per Night

Former Client and Three-Decade Data Sciences Leader John Reynders, PhD, Joins Rancho BioSciences Leadership on Board of Directors

This appointment reflects the company's continued growth through investment in leadership that pairs deep scientific credibility with real-world R&D experience...

Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.

Dysport® achieved statistically significant topline Phase III results, meeting primary endpoints in both episodic (E-BEOND) and chronic (C-BEOND) migraineDysport is...

error: Content is protected !!